#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5672	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2246	489.5	0	.	n	.	0	C451T	SNP	451	451	C	656	656	T	554	T,C,G,A	286,97,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5672	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2246	489.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1389	1389	C	714	C,G,A	467,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11412	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3801	572.1	0	.	n	.	0	T695C	SNP	695	695	T	1287	1287	C	819	C,T,A,G	513,2,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11412	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3801	572.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2563	2563	C	617	C,T,G	402,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11412	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3801	572.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2637	2637	A	634	A	413	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11412	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3801	572.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3189	3189	C	701	C,A,T	458,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	478	folP	855	855	100.0	folP.l15.c4.ctg.1	1676	54.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1143	1145	AGC	68;68;66	A;G;C	43;44;43	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1384	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3572	76.0	1	SNP	p	S91F	1	.	.	271	273	TTC	599	601	TTC	107;108;108	T;T;C,G	73;72;73,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1384	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3572	76.0	1	SNP	p	G95N	0	.	.	283	285	GGC	611	613	GGC	114;113;115	G;G;C	78;77;79	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1384	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3572	76.0	1	SNP	p	D95G	1	.	.	283	285	GGC	611	613	GGC	114;113;115	G;G;C	78;77;79	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	424	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1463	60.9	1	SNP	p	G45D	0	.	.	133	135	GGC	417	419	GGC	108;108;108	G;G;C	68;68;66	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	787	262	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	960	49.4	0	.	n	.	0	A197.	DEL	197	197	A	527	527	A	118	A	76	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3212	78.6	1	SNP	p	D86N	0	.	.	256	258	GAC	685	687	GAC	103;103;107	G,T,C;A,C;C,A	65,1,1;68,1;72,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3212	78.6	1	SNP	p	R87W	0	.	.	259	261	CGT	688	690	CGT	106;107;107	C;G;T,C	78;73;73,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3212	78.6	1	SNP	p	R87I	0	.	.	259	261	CGT	688	690	CGT	106;107;107	C;G;T,C	78;73;73,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3212	78.6	1	SNP	p	S87R	1	.	.	259	261	CGT	688	690	CGT	106;107;107	C;G;T,C	78;73;73,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1292	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3212	78.6	1	SNP	p	S88P	0	.	.	262	264	TCC	691	693	TCC	107;106;104	T;C,G;C	76;75,1;77	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	912	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2727	64.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1785	1787	GGC	70;71;71	G;G;C	49;49;52	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1239	1241	GCC	134;134;134	G,T;C,G;C	94,1;94,1;95	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1242	1244	ATG	134;132;132	A;T,A;G	94;92,2;94	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1254	1256	ACC	129;131;131	A,C,G;C,A;C	89,1,1;92,1;94	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1254	1256	ACC	129;131;131	A,C,G;C,A;C	89,1,1;92,1;94	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1755	1757	ACC	89;90;89	A,C;C;C	54,1;56;57	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1809	1811	GCG	60;60;60	G;C;G	44;40;45	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1809	1811	GCG	60;60;60	G;C;G	44;40;45	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1932	1934	GGT	49;49;50	G;G,C,T;T	34;32,1,1;35	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1941	1943	GGC	42;42;42	G;G,C,T;C,G	28;27,1,1;27,1	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	1056	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2214	88.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1959	1961	CCG	42;41;41	C;C,A;G,T	30;24,1;28,1	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2006	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3026	122.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1595	1597	CCG	79;79;79	C,T;C;G	51,1;50;50	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	708	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1809	78.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	691	691	C	72	C	43	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	62	porB1a	984	264	90.3	porB1a.l15.c4.ctg.1	1344	10.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1105	1107	AAT	18;18;18	A;A;T,G	13;13;12,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	62	porB1a	984	264	90.3	porB1a.l15.c4.ctg.1	1344	10.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1108	1110	AAT	18;18;18	A;A;T	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	62	porB1a	984	264	90.3	porB1a.l15.c4.ctg.1	1344	10.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1132	1134	GCA	11;11;11	G;C;A,C	7;6;6,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	62	porB1a	984	264	90.3	porB1a.l15.c4.ctg.1	1344	10.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1155	1157	GTA	11;11;11	G;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	62	porB1a	984	264	90.3	porB1a.l15.c4.ctg.1	1344	10.4	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1164	1164	A	11	A	7	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	754	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1611	90.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	395	397	GTT	116;114;114	G;T;T	74;73;73	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	754	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1611	90.1	0	.	p	.	0	G48A	NONSYN	142	144	GGA	404	406	GCA	112;112;111	G,T;C;A	71,1;70;70	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	754	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1611	90.1	1	SNP	p	G120K	1	.	.	358	360	AAG	620	622	AAG	100;100;103	A;A,G,C;G	68;66,1,1;71	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	754	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1611	90.1	1	SNP	p	A121N	1	.	.	361	363	AAC	623	625	AAC	105;105;103	A;A;C,G	72;73;69,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	754	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1611	90.1	1	SNP	p	N121D	0	.	.	361	363	AAC	623	625	AAC	105;105;103	A;A;C,G	72;73;69,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2692	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4878	107.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	286	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1082	53.2	1	SNP	p	V57M	1	.	.	169	171	ATG	544	546	ATG	117;112;112	A;T;G,T	78;75;74,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
